Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy

Cellular Physiology and Biochemistry

Volumn 36, Issue 5, 2015, Pages 1793-1808

  Liang, Yan ^a,b   Zhang, Junjun ^a,b   Zhou, Yali ^a   Xing, Guolan ^a   Zhao, Guoqiang ^b   Liu, Zhangsuo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cytokines; IgA nephropathy; Mesangial cells; MIR 16; Saliva; Secretory IgA

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTATIN C; CYTOKINE; FIBRONECTIN; IMMUNOGLOBULIN A; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; POLYMERIC IMMUNOGLOBULIN A; SECRETORY IMMUNOGLOBULIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UREA;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE REPRESSION; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLAMMATION; KIDNEY BIOPSY; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PRIORITY JOURNAL; SERUM; SINGLE BLIND PROCEDURE; SYSTEMATIC REVIEW; TISSUE SECTION; UREA NITROGEN BLOOD LEVEL; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; ISOLATION AND PURIFICATION; MESANGIUM; METABOLISM; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; FEMALE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MALE; MIDDLE AGED;

EID: 84937787857     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430151     Document Type: Article

References (50)

1. Berger J, Hinglais N: Intercapillary deposits of IgA-IgG. J Urol Nephrol 1968;74:694-695.
2. Oortwijn BD, van der Boog PJ, Roos A, van der Geest RN, de Fijter JW, Daha MR, van Kooten C: A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 2006;69:1131-1138.
3. Kerr MA: The structure and function of human IgA. Biochem J 1990;271:285-296.
4. Mathias A, Corthésy B: Recognition of gram-positive intestinal bacteria by hybridoma-and colostrums-derived secretory immunoglobulin A is mediated by carbohydrates. J Biol Chem 2011;286:17239-17247.
5. Vincent C, Cozon G, Zittoun M, Mellquist M, Kazatchkine MD, Czerkinsky C, Revillard JP: Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients. J Clin Immunol 1992;12:381-388.
6. Zhang JJ, Xu LX, Liu G, Zhao MH, Wang HY: The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes. Nephrol Dial Transplant 2008;23:207-212.
7. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985;28:666-671.
8. Smith AC, Molyneux K, Feehally J, Barratt J: O-Glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006;17:3520-3528.
9. Otani M, Nakata J, Kihara M, Leroy V, Moll S, Wada Y, Izui S: O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis. J Am Soc Nephrol. 2012;23:438-446.
10. Hiemstra PS, Gorter A, Stuurman ME, Van Es LA, Daha MR: Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 1987;17:321-326.
11. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR: Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001;167:2861-2868.
12. Kim MJ, McDaid JP, McAdoo SP, Barratt J, Molyneux K, Masuda ES, Pusey CD, Tam FW: Spleen tyrosine kinase is important in the production and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy. J Immunol 2012;189:3751-3758.
13. Tam KY, Leung JC, Chan LY, Lam MF, Tang SC, Lai KN: Macromolecular IgA1 taken from patients with familial IgA Nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int 2009;75:1330-1339.
14. Wang J, Cao J: Gene expression analysis in tubule interstitial compartments reveals candidate agents for IgA nephropathy. Kidney Blood Press Res 2014;39:361-368.
15. Szeto CC, Li PK: MicroRNAs in IgA nephropathy. Nat Rev Nephrol 2014;10:249-256.
16. Greenhill CJ, Rose-John S, Lissilaa R, Ferlin W, Ernst M, Hertzoq PJ, Mansell A, Jenkins BJ: IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol 2011;186:1199-1208.
17. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 1999;130:461-470.
19. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, Christensson A: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005;51:1420-1431.
20. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-545.
21. Gao YH, Xu LX, Zhang JJ, Zhang Y, Zhao MH, Wang HY: Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules. Clin Exp Immunol 2007;148:507-514.
22. Leung JC, Tang SC, Chan LY, Chan WL: Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA-role of MAPK and NF-kappaB. Nephrol Dial Transplant 2008;23:72-81.
23. Zhou R, Li X, Hu G, Gong AY, Drescher KM, Chen XM: miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PloS One 2012;7:e30772.
24. Lai KN: Pathogenesis of IgA nephropathy. Nat. Rev. Nephrol 2012;8:275-283.
25. Tomino Y: Pathogenesis and treatment of chronic kidney disease: A review of our recent basic and clinical data. Kidney Blood Press Res 2014;39:450-489.
26. Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C: The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol 2008;28:58-65.
27. Oortwijn BD, Rastaldi MP, Roos A, Mattinzoli D, Daha MR, van Kooten C: Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol Dial Transplant 2007;22:3191-3195.
28. Akagi H, Kosaka M, Hattori K, Doi A, Fukushima K, Okano M, Kariya S, Nishizaki K, Sugiyama N, Shikata K, Makino H, Masuda Y: Long-term results of tonsillectomy as a treatment for IgA nephropathy. Acta Otolaryngol 2004;555:S38-42.
29. Yasumori R: Measurement of secretory IgA in salivary juice and the localization of secretory IgA in duodenal mucosa in patients with IgA nephropathy. Nihon Jinzo Gakkai Shi. 1990;32:171-181.
30. Smith AC, Molyneux K, Feehally J, Barratt J: O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006;17:3520-3528.
31. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy defferentially affect proliferation of mesangial cells. Kidney Int 2005;67:504-513.
32. Liu LL, Liu N, Chen Y, Wang LN, Jiang Y, Wang J, Li XL, Yao L, Fan QL: Glomerular mannose-bingidng lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy. Clin Exp Immunol 2013;174:152-160.
33. Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M: IgA production and tonsillar focal infection in IgA nephropathy. J Clin Exp Hematop 2012;52:161-170.
34. Lawrence HP, Fillery ED, Matear DW, Paterson L, Hawkins RJ, Locker D: Salivary sIgA and cortisol: markers for functional dependence in older adults. Spec Care Dentist 2005;25:242-252.
35. Warner RH, Stevens FM, McCarthy CF: Salivary SIgA and SIgA1 in celiac disease, inflammatory bowel disease and controls. Ir J Med Sci 1999;168:33-35.
36. Eijgenraam JW, Oortwijn BD, Kamerling SW, de Fijter JW, van den Wall Bake AW, Daha MR, van Kooten C: Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response. Clin Exp Immunol 2008;152:227-232.
37. Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H: IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1. Adv Otorhinolaryngol 2011;72:68-70.
38. Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S: IgA nephropathy and tonsils-an approach from the structure of IgA1 produced by tonsillar lymphocytes. Acta Otolaryngol 2004;555:S28-31.
39. Donderski R, Szczepanek J, Domagalski K, Tretyn A, Korenkiewicz J, Marszaek A, Szymaski A, Wolski Z, Odrow-Sypniewska G, Manitius J: Analysis of relative expression level of VEGF ( vascular endothelial growth factor), HIF-1 ( hypoxia inducible factor 1) and CTGF ( connective tissue growth factor) genes in chronic glomerulonephritis (CGN) patients. Kidney Blood Press Res 2013;38:83-91.
40. Libetta C, Rampino T, Palumbo G, Esposito C, Dal Canton A: Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol 1997;8:208-213.
41. Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, Lou T, Zhang H: Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-1 synthesis in podocytes via rennin-angiotensin system activation. Arch Med Res 2010;41:255-260.
42. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY: Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 2004;136;168-175.
43. Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC: Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005;16:2667-2676.
44. Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C: Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 2006;17:3529-3539.
45. Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, Vlachojannis JG: Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant 2002;17:2145-2152.
46. Li XZ, Feng JT, Hu CP, Chen ZQ: Does arcadia contribute to TGF-1-induced IgA expression through up-regulation of smad signaling in IgA nephropathy Int Urol Nephrol 2010;42:719-722.
47. Le W, Liang S, Chen H, Wang S, Zhang W, Wang X, Wang J, Zeng CH, Liu ZH: Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria. Am J Nephrol 2014;40:43-50.
48. Li W, Zang W, Liu P, Wang Y, Du Y, Chen X, Deng M, Sun W, Wang L, Zhao G, Zhai B: MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol 2014;35:10897-10904.
49. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J: Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005;120:623-634.
50. Anderson P: Post-transcriptional control of cytokine production. Nat Immunol 2008;9:353-359.